News
FDA rejects MDMA in combination with therapy as treatment for PTSD© Pymca/avalon/Avalon via Getty Images Ecstasy pills in ...
The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...
Sally Roberts, a world-class wrestler and Army veteran, credits psychedelic-assisted therapy with saving her life from PTSD. She joined other veterans and advocates this week to urge North ...
60 Minutes joined U.S. veterans with PTSD on a week-long psychedelic retreat in Mexico. Nearly a year later, most of the vets said the experience with psilocybin was life-changing.
The Trump administration shows interest in psychedelic research for treating PTSD and mental health disorders, as clinical trials demonstrate potential benefits of MDMA and psilocybin.
Texas Will Invest $50 Million in Ibogaine Research, Testing the Psychedelic Drug’s Medical Potential The state’s new law marks one of the largest government investments into psychedelics to ...
HHS secretary Robert F. Kennedy Jr. declared that the FDA’s “suppression of psychedelics” was about to end. Now he and his allies may be in position to do something about it.
Schematic of the proposed DDHD2 and NMT1/2 pathway for synaptic plasticity and memory. Credit: The EMBO Journal (2025). DOI: 10.1038/s44318-025-00484-3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results